First Time Loading...

Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 168.5 SEK 1.81% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

BIOT Price Targets Summary
Biotage AB

Wall Street analysts forecast BIOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOT is 207.83 SEK with a low forecast of 161.6 SEK and a high forecast of 267.75 SEK.

Lowest
Price Target
161.6 SEK
4% Downside
Average
Price Target
207.83 SEK
23% Upside
Highest
Price Target
267.75 SEK
59% Upside
Biotage AB Competitors:
Price Targets
MRVI
Maravai LifeSciences Holdings Inc
30% Upside
DIVISLAB
Divi's Laboratories Ltd
17% Downside
LONN
Lonza Group AG
5% Upside
BIO
Bio Rad Laboratories Inc
49% Upside
ILMN
Illumina Inc
26% Upside
4880
CellSource Co Ltd
21% Upside
4YL
Nanoform Finland Oyj
63% Upside
207940
Samsung Biologics Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 14%.

15%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 23%.

21%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 24%.

16%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOT's stock price target?
Price Target
207.83 SEK

According to Wall Street analysts, the average 1-year price target for BIOT is 207.83 SEK with a low forecast of 161.6 SEK and a high forecast of 267.75 SEK.

What is Biotage AB's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 14%.

What is Biotage AB's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 23%.

What is Biotage AB's Net Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 24%.